TMTPOST --   U.S. President Donald   Trump on Thursday previewed a   new wave   of   sectoral   tariffs   up to 100%   coming next month.

AI Generated Image

  In a slew   of posts on his social media   platform Truth Social, Trump   announced he   will impose a 100% tariff on all branded   or patented   pharmaceutical   products, a 50% Tariff on all Kitchen Cabinets, Bathroom Vanities, and associated products,   a 30% Tariff on Upholstered Furniture, and a 25% tariff   on all heavy   trucks. All   of   these levies will   come   into effect on   October 1.

Trump said the new tariffs on   kitchen and bathroom cabinets,   along with certain furniture, resulted from other countries ’   large scale of   "flooding"   into   the United States, which he described   as "very unfair"   practice. The   tariffs   aim   to protect the U.S. manufacturing   for national security, among other reasons.  

The   heavy   truck levies   are also part of efforts to save   domestic   manufacturers. They will protect   U.S. companies, such as Peterbilt, Kenworth, Freightliner, Mack Trucks,   from "the onslaught of outside interruptions", Trump said, citing reasons, including   "above all   else", national security.

As   to the   drug tariffs, Trump said   companies   "building"   their pharmaceutical manufacturing plants   in America   would   be exempted from such levies.   He clarified that   the "building"   means the   plant   is "breaking ground"   and/or   "under   construction".    "There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started,"   the   president wrote   in his   post.

The Trump administration has already used this tool to raise levies on aluminum, cars, car parts, and steel, and has launched 232 investigations into seven other types of products   such as pharmaceuticals, lumber, semiconductors.  

The new   drug   tariffs could impact major producers of branded pharmaceuticals - including the UK, Ireland, Germany, Switzerland and Japan.   In 2024, U.S. imports of pharmaceuticals nearly tripled to around $213 billion from a decade earlier, according to data from the United Nations Comtrade Database.

The threat   of tariffs   on   pharmaceutical imports   has been   intensified   since   the Trump administration in April opened   a   Section 232 investigation into how importing certain   pharmaceutical products   affects national security.   The move   was   widely   seen as a   prelude to initiating tariffs on drugs.

Trump during a   Cabinet   meeting on July 8 disclosed steep tariffs on the pharmaceutical sector will be announced "very soon", while he could offer the pharmaceutical manufacturers at least a year for transition of their production to the U.S. before implementing the tariffs up to 200%.

The White House   in late   July   said Trump   had sent letters to 17 major pharmaceutical firms in   the West outlining the steps they must take to lower the price of U.S. prescription drugs to "most favored nation" ( MFN ) levels by September   29.   

Trump in   the letter warned   if these companies   "refuse to step up," the   U.S.   government will deploy every tool in its "arsenal to protect American families from continued abusive drug pricing practices,"   without specifying   the   possible measures.  

Trump last month   threatened   pharmaceutical tariffs potentially reaching up to 250% over time. "We'll be putting a initially small tariff on pharmaceuticals, but in one year — one and a half years, maximum — it's going to go to 150%. And then it ’ s going to go to 250%, because we want pharmaceuticals made in our country," Trump said on August 5.